Overcoming Resistance: FLT3 Inhibitors Past, Present, Future and the Challenge of Cure

SIMPLE SUMMARY: Despite the recent approval of some FLT3 inhibitors by drug regulatory agencies, treatment guidelines for FLT3-mutated AML still require allogeneic transplantation as a necessary procedure to treat the disease in first or second CR, due to the high relapse incidence related to the us...

Descripción completa

Detalles Bibliográficos
Autores principales: Capelli, Debora, Menotti, Diego, Fiorentini, Alessandro, Saraceni, Francesco, Olivieri, Attilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454516/
https://www.ncbi.nlm.nih.gov/pubmed/36077850
http://dx.doi.org/10.3390/cancers14174315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454516/
https://www.ncbi.nlm.nih.gov/pubmed/36077850
http://dx.doi.org/10.3390/cancers14174315

Ejemplares similares